Carindacillin
Penicillin-class Antibacterial — ANTIINFECTIVES FOR SYSTEMIC USE
Also known as: carbenicillin indanyl, carbenicillin indanyl ester, carbenicillin indanyl sodium, cardinacillin, carindacillin sodium, CP-15464-2, indanyl carbenicillin
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Carindacillin is an ofm drug in the Penicillin-class Antibacterial class catalogued in DrugCentral. It was first approved by the FDA in 1972. DrugCentral lists 1 molecular target, including mrcA|mrcB|dacC|mrdA|ftsI|dacA|dacB. Recorded indications include Bacterial urinary infection.
- Approval status: ofm (first approved 1972 by the FDA).
- Drug class: Penicillin-class Antibacterial.
- Molecular targets: mrcA|mrcB|dacC|mrdA|ftsI|dacA|dacB (1 listed in DrugCentral).
- Indications: Bacterial urinary infection.
- ATC code: J01CA05 (Penicillins with extended spectrum).
- Molecular formula: C26H26N2O6S; molecular weight 494.56 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Bacterial urinary infection
Mechanism & targets
| Established pharmacologic class | Penicillin-class Antibacterial |
|---|
Molecular targets (1)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Bacterial penicillin-binding protein | mrcA|mrcB|dacC|mrdA|ftsI|dacA|dacB | inhibitor | — |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1972-10-26 | FDA | — | PFIZER |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
J01CA05 | ANTIINFECTIVES FOR SYSTEMIC USE › ANTIBACTERIALS FOR SYSTEMIC USE › BETA-LACTAM ANTIBACTERIALS, PENICILLINS › Penicillins with extended spectrum |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Carindacillin is on its molecule page.
| Molecular formula | C26H26N2O6S |
|---|---|
| Molecular weight | 494.56 g/mol |
| CAS number | 35531-88-5 |
| InChIKey | JIRBAUWICKGBFE-MNRDOXJOSA-N |
| PubChem CID | 20824 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Carindacillin used for?
DrugCentral lists the following indications for Carindacillin: Bacterial urinary infection.
How does Carindacillin work?
Its molecular targets in DrugCentral include mrcA|mrcB|dacC|mrdA|ftsI|dacA|dacB (inhibitor).
When was Carindacillin first approved?
Carindacillin was first approved by the FDA in 1972.
What drug class does Carindacillin belong to?
Carindacillin is in the Penicillin-class Antibacterial class.
What is the chemical formula of Carindacillin?
Carindacillin has the molecular formula C26H26N2O6S and a molecular weight of 494.56 g/mol.
Browse: all drugs starting with C · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 508 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1200991 — compound record and bioactivity
- PubChem CID 20824 — chemical identifiers
- DrugBank DB00578 — drug record
- FDA UNII 5V278481KE — substance identity
- DailyMed: FDA labels for Carindacillin — current prescribing information (label search)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.